Dennis Slamon is Director of BIOMARIN PHARMACEUTICAL INC. Currently has a direct ownership of 31,299 shares of BMRN, which is worth approximately $1.98 Million. The most recent transaction as insider was on Mar 18, 2024, when has been sold 9,510 shares (Common Stock) at a price of $83.81 per share, resulting in proceeds of $797,033. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.3K
0% 3M change
1.59% 12M change
Total Value Held $1.98 Million

Dennis Slamon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 18 2024
SELL
Payment of exercise price or tax liability
$797,033 $83.81 p/Share
9,510 Reduced 23.3%
31,299 Common Stock
Mar 18 2024
BUY
Exercise of conversion of derivative security
$797,000 $79.7 p/Share
10,000 Added 19.68%
40,809 Common Stock
May 23 2023
BUY
Grant, award, or other acquisition
-
4,190 Added 11.97%
30,809 Common Stock
May 24 2022
BUY
Grant, award, or other acquisition
-
4,980 Added 15.76%
26,619 Common Stock
Feb 28 2022
SELL
Open market or private sale
$501,127 $78.35 p/Share
6,396 Reduced 22.81%
21,639 Common Stock
May 25 2021
BUY
Grant, award, or other acquisition
-
5,120 Added 15.44%
28,035 Common Stock
DS

Dennis Slamon

Director
San Rafael, CA

Track Institutional and Insider Activities on BMRN

Follow BIOMARIN PHARMACEUTICAL INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BMRN shares.

Notify only if

Insider Trading

Get notified when an Biomarin Pharmaceutical Inc insider buys or sells BMRN shares.

Notify only if

News

Receive news related to BIOMARIN PHARMACEUTICAL INC

Track Activities on BMRN